- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
The Rotavirus Molecular Diagnostics market is a subset of the larger Infectious Disease Testing market. It is focused on the detection and diagnosis of rotavirus, a virus that is the leading cause of severe diarrhea in infants and young children. Molecular diagnostics are used to detect the presence of the virus in a sample, and can be used to differentiate between different strains of the virus. Molecular diagnostics are often used in combination with other tests, such as ELISA, to provide a more comprehensive diagnosis.
The Rotavirus Molecular Diagnostics market is driven by the need to accurately diagnose and treat rotavirus infections. This is especially important in developing countries, where the virus is more prevalent and access to healthcare is limited.
Companies in the Rotavirus Molecular Diagnostics market include Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more